D. Mest

Safety of Sculptra®: a review of clinical trial data

P. Engelhard, G. Humble, D. Mest, 2005, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.

Nasal colonization with methicillin-resistant Staphylococcus aureus on admission to the surgical intensive care unit increases the risk of infection.

S. Wilson, D. Wong, M. Mulligan, 1994, Anesthesia and analgesia.

Injectable Poly‐l‐Lactic Acid for Human Immunodeficiency Virus–Associated Facial Lipoatrophy: Cumulative Year 2 Interim Analysis of an Open‐Label Study (FACES)

A. LaMarca, M. Gold, M. Conant, 2012, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Safety and Efficacy of Poly‐L‐lactic Acid Injections in Persons with HIV‐Associated Lipoatrophy: The US Experience

G. Humble, D. Mest, 2006, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Poly-l-Lactic Acid for the Treatment of HIV-Associated Facial Lipoatrophy

G. Humble, D. Mest, 2012 .

Retreatment with Injectable Poly‐l‐Lactic Acid for HIV‐Associated Facial Lipoatrophy: 24‐Month Extension of the Blue Pacific Study

G. Humble, D. Mest, 2009, Dermatologic Surgery.

Duration of Correction for Human Immunodeficiency Virus-Associated Lipoatrophy After Retreatment with Injectable Poly-l-Lactic Acid

G. Humble, D. Mest, 2009, Aesthetic Plastic Surgery.

Soft tissue augmentation using sculptra.

G. Humble, D. Mest, 2004, Facial plastic surgery : FPS.

Expert Recommendations on the Use of Injectable Poly-L-lactic Acid for Contour Deficiencies of the Buttocks

N. Sadick, Alessandra Haddad, L. Avelar, 2021, Journal of Drugs in Dermatology.

Injectable Poly‐l‐Lactic Acid for Human Immunodeficiency Virus–Associated Facial Lipoatrophy: Cumulative Year 2 Interim Analysis of an Open‐Label Study (FACES)

A. LaMarca, M. Gold, M. Conant, 2012, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].